November 26th, 2014
•We describe a protocol for deriving lentiviral-based reprogrammed and characterized factor-free human induced pluripotent stem cells and conversion into putative clinical-grade conditions.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved